Issues
-
Cover Image
Cover Image
About the Cover
Regulatory T cells contribute to the protumor environment in cancer. Large numbers in tumors, or a high regulatory T:CD8+ T cell ratio, is associated with a poor prognosis. However, that relationship is not always found in urinary bladder cancer. Winerdal et al. first established that the regulatory T cells in human bladder cancers are functionally suppressive like other regulatory T cells. They then observed that these regulatory T cells suppressed tumor and macrophage production of MMP2, a metalloproteinase that aids metastasis. Thus, higher numbers of regulatory T cells congregating at the invasive front of a tumor correlated with survival. Read more in this issue on page 528. Original micrograph from the Winqvist laboratory shows a bladder tumor infiltrated and surrounded by brown T cells, some of which are regulatory. Artwork by Lewis Long. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Cancer Immunology Research
Cancer Immunology Research, launched in 2013 with Glenn Dranoff as founding Editor-in-Chief, is published by the AACR. The Journal illuminates the interplay between tumors and the immune system, with Robert D. Schreiber and Philip D. Greenberg serving as the Editors-in-Chief.
Table of Contents
What We’re Reading
Cancer Immunology at the Crossroads
Priority Brief
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
Research Articles
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression
Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer
Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation
MDSCs from HNSCC patients exhibited upregulated caspase-1, a member of the inflammasome complex, and directly promoted tumor cell proliferation. Silencing caspase-1 activity in a mouse model reduced tumor growth, suggesting that targeting caspase-1 could have therapeutic potential.
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression
Journal Archive
Cancer Immunology Research
(2013-Present)Published monthly since 2013.
(ISSN 2326-6066)
Cancer Immunity
(2001-2013; volumes 1-13)Published periodically from 2001-2013.
(EISSN 1424-9634)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.